Table 7KQ1 summary of findings and strength of evidence for biomarkers

KQ1 Diagnostic TestOutcomeNumber of Studies and IDsFindingsReasons for DowngradingSoE
KQ1 Biomarkers (biospecimen)Sensitivity7 studies309, 501, 563, 583, 603, 635, 644Sensitivity ranged from 56% (corresponding specificity 95%)501 to100% (corresponding specificity 100%) using a serum marker309 differentiating ADHD and neurotypical developmentS, ILow
KQ1 Blood biomarkersSensitivity2 studies309, 563Sensitivity ranged from 79% (corresponding specificity 25%)563 to 100% (corresponding specificity 100%) using a serum marker309S, ILow
KQ1 miRNA biomarkersSensitivity3 studies603, 635, 644Sensitivity ranged from 68% (corresponding specificity 71%)635 to 90% (corresponding specificity 80%)603S, ILow
KQ1 urine markersSensitivity2 studies501, 583Sensitivity ranged from 56% (corresponding specificity 95%)501 to 94% (corresponding specificity 83%)583S, ILow
KQ1 Biomarkers (biospecimen)Specificity7 studies309, 501, 563, 583, 603, 635, 644Specificity ranged from 25% (corresponding sensitivity 79%)563 to 100% (corresponding sensitivity 100%) using a serum marker309 differentiating ADHD and neurotypical developmentS, ILow
KQ1 Blood biomarkersSpecificity2 studies309, 563Specificity ranged from 25% (corresponding sensitivity 79%)563 to 100% (corresponding sensitivity 100%)309S, ILow
KQ1 miRNA biomarkersSpecificity3 studies603, 635, 644Specificity ranged from 71% (corresponding specificity 68%)635 to 95% (corresponding sensitivity 82%)635S, ILow
KQ1 urine markersSpecificity2 studies501, 583Specificity ranged from 80% (corresponding sensitivity 88%)501 to 95% (corresponding sensitivity 56%)501S, ILow
KQ1 Biomarkers (biospecimen)Accuracy2 studies563, 603Accuracy ranged from 55% using a blood marker563 to 85% using miRNA603 differentiating ADHD and neurotypical developmentS, CLow
KQ1 Biomarkers (biospecimen)AUC4 studies309, 583, 603, 644AUC ranged from 0.68603 using mIRNA635 to 1.00309 using a serum marker differentiating ADHD and neurotypical developmentS, CLow
KQ1 Biomarkers (biospecimen)Rater agreement0 studiesNo dataCInsufficient
KQ1 Biomarkers (biospecimen)Internal consistency0 studiesNo dataCInsufficient
KQ1 Biomarkers (biospecimen)Test-retest reliability0 studiesNo dataCInsufficient
KQ1 Biomarkers (biospecimen)Misdiagnosis impact0 studiesNo dataCInsufficient

Notes: ADHD = attention deficit hyperactivity disorder, AUC = area under the curve, C = inconsistency, I = imprecision, Key Question = Key Question, S = study limitation, SoE = strength of evidence

From: 4, Results: Diagnosis of ADHD

Cover of ADHD Diagnosis and Treatment in Children and Adolescents
ADHD Diagnosis and Treatment in Children and Adolescents [Internet].
Comparative Effectiveness Review, No. 267.
Peterson BS, Trampush J, Maglione M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.